2025-01-22 17-53-15
Content
- GLP-1 Receptor Agonists can improve Neuropathy in patients with Type 2 Diabetes
References
| Original Sources1 | Citations |
|---|---|
| dhanapalaratnamGlucagonlikePeptide1Receptor2024 | Dhanapalaratnam, Roshan, Tushar Issar, Alexandra T. K. Lee, Ann M. Poynten, Kerry-Lee Milner, Natalie C. G. Kwai, and Arun V. Krishnan. “Glucagon-like Peptide-1 Receptor Agonists Reverse Nerve Morphological Abnormalities in Diabetic Peripheral Neuropathy.” Diabetologia 67, no. 3 (March 2024): 561–66. https://doi.org/10.1007/s00125-023-06072-6. |